Fundraising Fox
Laplace Interventional
Plymouth, US · Founded 2020 · 20 employees on LinkedIn · 7 known investors
Find your way into Laplace Interventional
Sign up to see every warm intro you have to Laplace Interventional
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Laplace Interventional team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.
Founders & leadership
Laplace Interventional was founded in 2020 by Ramji Iyer.
Board
Investors · 7
How we know: a partner's Signal profile · press coverage · Not right? Tell us
How we know: Features Capital Holdings's portfolio page · Not right? Tell us
How we know: ShangBay Capital LLC's portfolio page · a partner's Signal profile · Not right? Tell us
How we know: Unorthodox Ventures's portfolio page · press coverage · Not right? Tell us
How we know: press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$42M disclosed across 3 rounds · 2021–2025
▶$21.2MraisedFeb 2025 · 6 investors · Other Health CareRule 506(b)
- Jenny H. BarbaDirector
- Todd MortierDirector
- Colin MorrisonDirector
- Ramji IyerExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $21.2M
- First sale
- Feb 2025
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$12.9MraisedJul 2023 · 9 investors · Other Health CareRule 506(b)
- Jenny BarbaDirector
- Ramji IyerExecutive Officer, Director
- Todd MortierDirector
- William DaiDirector
- Offering amount
- $12.9M
- Amount sold
- $12.9M
- First sale
- Jul 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$7.9MraisedSep 2021 · 8 investors · Other Health CareRule 506(b)
- Ramji IyerExecutive Officer, Director
- Offering amount
- $7.9M
- Amount sold
- $7.9M
- Minimum investment
- $25K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
Companies working in the same space as Laplace Interventional.
In the news
Frequently asked questions
- What does Laplace Interventional do?
- Laplace Interventional develops a transcatheter tricuspid valve replacement system that delivers a prosthetic valve percutaneously, avoiding open-heart surgery for patients with tricuspid regurgitation. The company is a medical device developer based in the United States.
- Who founded Laplace Interventional?
- Laplace Interventional was founded by Ramji Iyer in 2020.
- Who are Laplace Interventional's investors?
- Laplace Interventional's investors include Aphelion Capital, Features Capital Holdings, gener8tor, ShangBay Capital LLC, Unorthodox Ventures, Aphelion Cardeation, Engage Venture Partners.
- How much funding has Laplace Interventional raised?
- Laplace Interventional has disclosed $42M raised across 3 rounds.
- Where is Laplace Interventional headquartered?
- Laplace Interventional is headquartered in Plymouth, US.